Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectal vs oral omeprazole for gastroesophageal reflux in infants with esophageal atresia or congenital diaphragmatic hernia
2013-002026-22Phase 4Active
- Sponsor
- Erasmus MC
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of omeprazole in gastroesophageal reflux disease (GERD) (2 arms), sponsored by Erasmus MC. Primary endpoint: Treatment effectiveness based on gastric pH and clinical findings. Started Jun 2013; status: active.
02
Drugs
omeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on 2013-002026-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002026-22.